Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Level of lactate in amniotic fluid and its relation to the use of oxytocin and adverse neonatal outcome
Acta Obstetricia et Gynecologica Scandinavica, Volume 93, No. 1, Year 2014
Notification
URL copied to clipboard!
Description
Objective To assess whether the frequency of adverse neonatal outcome at delivery is related to the level of lactate in amniotic fluid and to the use of oxytocin. Design Prospective observational study. Setting Soder Hospital, Stockholm, Sweden. Population Seventy-four women in active labor with a gestational age ≥36 weeks and mixed parity. Methods Levels of lactate in amniotic fluid were analyzed bedside from an intrauterine catheter every 30 min during labor. Deliveries were divided into groups with and without oxytocin. Main outcome measures The frequency of adverse neonatal outcome at delivery. Result Of the deliveries 13.5% (10/74) concluded with an adverse neonatal outcome. The levels of lactate in amniotic fluid increased during labor, more so in deliveries where oxytocin was used. In the group with an adverse neonatal outcome, the level of lactate in amniotic fluid was significantly higher in the final sample before delivery (p = 0.04). In 18 deliveries, stimulation with oxytocin was temporarily halted for at least 30 min due to overly stimulated labor contractions. A decreasing level of lactate in amniotic fluid was shown within a median 5%/30 min. In the group where the administration of oxytocin was halted, there was no adverse neonatal outcome. Conclusion The frequency of adverse neonatal outcome was associated with the level of lactate in amniotic fluid and with the use of oxytocin. The level of lactate in amniotic fluid may be an additional valuable tool when oxytocin is administered during labor. © 2013 Nordic Federation of Societies of Obstetrics and Gynecology.
Authors & Co-Authors
Wiberg-Itzel, Eva
Sweden, Stockholm
Södersjukhuset
Pembe, Andrea Barnabas
Tanzania, Dar es Salaam
Muhimbili University of Health and Allied Sciences
Wray, Susan C.
United Kingdom, Liverpool
University of Liverpool
Wihlbäck, Anna Carin
Sweden, Umea
Norrlands Universitetssjukhus
Darj, Elisabeth
Sweden, Uppsala
Uppsala Universitet
Hösli, Irene Mathilde
Switzerland, Basel
Universitäts Frauenklinik, Universitätsspital Basel
Åkerud, Helena
Sweden, Uppsala
Uppsala Universitet
Statistics
Citations: 22
Authors: 7
Affiliations: 6
Identifiers
Doi:
10.1111/aogs.12261
ISSN:
00016349
e-ISSN:
16000412
Research Areas
Health System And Policy
Maternal And Child Health
Study Design
Cross Sectional Study
Cohort Study
Participants Gender
Female